Disruption of human TRIM5α antiviral activity by nonhuman primate orthologues

L Berthoux, S Sebastian, DM Sayah, J Luban - Journal of virology, 2005 - Am Soc Microbiol
L Berthoux, S Sebastian, DM Sayah, J Luban
Journal of virology, 2005Am Soc Microbiol
ABSTRACT TRIM5 is a determinant of species-specific differences in susceptibility to
infection by retroviruses bearing particular capsids. Human immunodeficiency virus type 1
(HIV-1) infection is blocked by the alpha isoform of macaque TRIM5 (TRIM5αrh) or by the
product of the owl monkey TRIM5-cyclophilin A gene fusion (TRIMCyp). Human TRIM5α
potently restricts specific strains of murine leukemia virus (N-MLV) but has only a modest
effect on HIV-1. The amino termini of TRIM5 orthologues are highly conserved and possess …
Abstract
TRIM5 is a determinant of species-specific differences in susceptibility to infection by retroviruses bearing particular capsids. Human immunodeficiency virus type 1 (HIV-1) infection is blocked by the alpha isoform of macaque TRIM5 (TRIM5αrh) or by the product of the owl monkey TRIM5-cyclophilin A gene fusion (TRIMCyp). Human TRIM5α potently restricts specific strains of murine leukemia virus (N-MLV) but has only a modest effect on HIV-1. The amino termini of TRIM5 orthologues are highly conserved and possess a coiled-coil domain that promotes homomultimerization. Here we show that heterologous expression of TRIM5αrh or TRIMCyp in human cells interferes with the anti-N-MLV activity of endogenous human TRIM5α (TRIM5αhu). Deletion of the cyclophilin domain from TRIMCyp has no effect on heteromultimerization or colocalization with TRIM5αhu but prevents interference with anti-N-MLV activity. These data demonstrate that TRIM5 orthologues form heteromultimers and indicate that C-terminal extensions alter virus recognition by multimers of these proteins.
American Society for Microbiology